PDB-3f15: Crystal structure of the catalytic domain of human mmp12 complexed with the inhibitor (S)-N-(2,3-dihydroxypropyl)-4-methoxy-N-(2-nitroso-2-oxoethyl)benzenesulfonamide 手法: X-RAY DIFFRACTION / 解像度: 1.7 Å
PDB-3f16: Crystal structure of the catalytic domain of human MMP12 complexed with the inhibitor (R)-N-(3-hydroxy-1-nitroso-1-oxopropan-2-yl)-4-methoxybenzenesulfonamide 手法: X-RAY DIFFRACTION / 解像度: 1.16 Å
PDB-3f17: Crystal structure of the catalytic domain of human MMP12 complexed with the inhibitor N-(2-nitroso-2-oxoethyl)biphenyl-4-sulfonamide 手法: X-RAY DIFFRACTION / 解像度: 1.1 Å
PDB-3f18: Crystal structure of the catalytic domain of human MMP12 complexed with the inhibitor 4-fluoro-N-(2-hydroxyethyl)-N-(2-nitroso-2-oxoethyl)benzenesulfonamide 手法: X-RAY DIFFRACTION / 解像度: 1.13 Å
PDB-3f19: Crystal structure of the catalytic domain of human MMP12 complexed with the inhibitor 4-fluoro-N-(2-nitroso-2-oxoethyl)benzenesulfonamide 手法: X-RAY DIFFRACTION / 解像度: 1.13 Å
PDB-3f1a: Crystal structure of the catalytic domain of human MMP12 complexed with the inhibitor N-(2-nitroso-2-oxoethyl)benzenesulfonamide 手法: X-RAY DIFFRACTION / 解像度: 1.25 Å
PDB-3lk8: Crystal structure of the catalytic domain of human MMP12 complexed with the inhibitor paramethoxy-sulfonyl-glycine hydroxamate 手法: X-RAY DIFFRACTION / 解像度: 1.8 Å
PDB-3nx7: Crystal structure of the catalytic domain of human MMP12 complexed with the inhibitor N-Hydroxy-2-(N-(2-hydroxyethyl)4-methoxyphenylsulfonamido)acetamide 手法: X-RAY DIFFRACTION / 解像度: 1.8 Å